Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(6 sites)
United States
University of California, San Francisco, San Francisco, California University of South Florida, Tampa, Florida Lahey Hospital and Medical Center, Burlington, Massachusetts Mayo Clinic, Rochester, Minnesota Duke University Health System, Durham, North Carolina Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio Last updated November 2025